Anavex Life Sciences Corp (AVXL)
SG&A Expenses
$2.39M
Quarterly · Period ending: · USD
AVXL SG&A Expenses
Latest reported$2.39Mperiod ending
Latest reported$2.39Mperiod ending
AVXL Quarterly SG&A Expenses ($0.00 → $2.39M)
Quarterly SG&A Expenses
High-resolution chart · PNG
AVXL sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 2,385,000 | |
| 2,292,000 | |
| 2,126,000 | |
| 3,550,000 | |
| 4,500,000 | |
| 2,621,000 | |
| 3,146,000 | |
| 2,781,000 | |
| 2,792,000 | |
| 2,895,000 | |
| 2,694,000 | |
| 2,591,553 | |
| 3,248,000 | |
| 2,883,000 | |
| 3,317,000 | |
| 3,902,508 | |
| 3,185,451 | |
| 2,915,158 | |
| 3,066,951 | |
| 2,878,983 | |
| 2,434,127 | |
| 2,233,745 | |
| 1,470,656 | |
| 1,402,955 | |
| 1,381,477 | |
| 1,720,142 | |
| 1,352,035 | |
| 1,635,312 | |
| 1,388,729 | |
| 2,061,251 | |
| 1,761,307 | |
| 1,481,538 | |
| 1,620,379 | |
| 1,489,450 | |
| 1,397,803 | |
| 1,361,051 | |
| 1,405,026 | |
| 1,116,014 | |
| 1,126,184 | |
| 2,243,905 | |
| 1,134,845 | |
| 1,089,641 | |
| 3,368,756 | |
| 3,220,234 | |
| 713,498 | |
| 451,193 | |
| 452,053 | |
| 295,319 | |
| 733,818 | |
| 903,015 | |
| 304,428 | |
| 1,368,655 | |
| 86,961 | |
| 126,551 | |
| 287,909 | |
| 527,962 | |
| 301,917 | |
| 364,587 | |
| 468,497 | |
| 632,233 | |
| 856,063 | |
| 1,215,328 | |
| 869,321 | |
| 872,624 | |
| 688,086 | |
| 701,732 | |
| 668,323 | |
| 729,852 | |
| 801,163 | |
| 441,060 | |
| 621,653 | |
| 1,600,115 | |
| 1,085,889 | |
| 436,086 | |
| 692,332 | |
| 248,794 | |
| 213,978 | |
| 143,240 | |
| 12,212 | |
| 5,730 | |
| 5,679 | |
| 4,660 | |
| 9,407 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |